Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsDividends payablesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Selectis Health (GBCS) Non-Current Debt (2018 - 2025)

Selectis Health's Non-Current Debt history spans 11 years, with the latest figure at $13.4 million for Q4 2025.

  • Quarterly results put Non-Current Debt at $13.4 million for Q4 2025, up 1576.5% from a year ago — trailing twelve months through Dec 2025 was $13.4 million (up 1576.5% YoY), and the annual figure for FY2025 was $13.4 million, up 1576.5%.
  • Non-Current Debt for Q4 2025 was $13.4 million at Selectis Health, down from $18.5 million in the prior quarter.
  • In the past five years, Non-Current Debt ranged from a high of $34.4 million in Q4 2022 to a low of $750000.0 in Q3 2022.
  • The 5-year median for Non-Current Debt is $25.2 million (2021), against an average of $22.2 million.
  • The sharpest move saw Non-Current Debt plummeted 97.76% in 2022, then soared 3356.36% in 2023.
  • Year by year, Non-Current Debt stood at $31.1 million in 2021, then increased by 10.76% to $34.4 million in 2022, then dropped by 26.81% to $25.2 million in 2023, then crashed by 96.82% to $799752.0 in 2024, then soared by 1576.5% to $13.4 million in 2025.
  • According to Business Quant data, Non-Current Debt over the past three periods came in at $13.4 million, $18.5 million, and $18.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.